How To Get A Goodrx Card

GoodRx is a health information services business based in the US. GoodRx stocks (GDRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $33.14 – a decrease of 4.77% over the previous week. GoodRx employs 450 staff and has a trailing 12-month revenue of around $685.7 million.

How to buy shares in GoodRx

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – GDRX – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
Check in on your investment. Optimize your portfolio by tracking your stock.

Promoted for

Savvy Investors

Is it a good time to buy GoodRx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

GoodRx stock price

Use our graph to track the performance of GDRX stocks over time.

GoodRx shares at a glance

Key figures

Information last updated 2021-11-14.

Latest market close	$39.95
52-week range	$26.66 - $59.67
50-day moving average	$42.97
200-day moving average	$37.69
Wall St. target price	$44.87
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.70

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Online stock trading

GoodRx price performance over time

Historical closes compared with the close of $39.95 from 2021-11-16

1 week (2021-11-11)	0.43%
1 month (2021-10-18)	-5.02%
3 months (2021-08-18)	14.44%
6 months (2021-05-18)	32.28%

1 year (2020-11-17)	10.33%
2 years (2019-11-14)	N/A
3 years (2018-11-14)	N/A
5 years (2016-11-14)	N/A

Is GoodRx under- or over-valued?

Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

GoodRx's EBITDA

GoodRx's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $79.1 million.

The EBITDA is a measure of a GoodRx's overall financial performance and is widely used to measure a its profitability.

GoodRx financials

Revenue TTM	$685.7 million
Gross profit TTM	$521.1 million
Return on assets TTM	-11.23%
Return on equity TTM	-35.39%
Profit margin	-41.36%
Book value	$2.06
Market capitalisation	$16.5 billion

TTM: trailing 12 months

GoodRx share dividends

We're not expecting GoodRx to pay a dividend over the next 12 months.

GoodRx overview

GoodRx Holdings, Inc. , through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

Stocks similar to GoodRx

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.